2-Methyl-N-[3-(trifluoromethyl)phenyl]propanamide is used as a reagent to synthesize Flutamide (F598850), an oral nonsteroidal antiandrogen that is hepatotoxic and commonly used to treat patients with prostate cancer.
參考文獻
Bandgar, B., et al.: Synthetic Commun., 36, 859 (2006); Foss?, S., et al.: J. Clin. Oncol., 19, 62 (2001); Sogani, P., et al.: Cancer, 54, 744 (1984); Wysowski, D., et al.: J. Urology, 155, 209 (1996)
滬ICP備17019645號
400-821-0725
